# Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients

> **NCT00001937** · PHASE3 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 800 (—)

## Conditions studied

- Aspergillosis
- Candidiasis
- Fungemia
- Mycoses

## Interventions

- **DRUG:** FK463
- **DRUG:** Fluconazole

## Key facts

- **NCT ID:** NCT00001937
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-11
- **Primary completion:** —
- **Final completion:** 2000-12
- **Target enrollment:** 800 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001937, "Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00001937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*